The iQue Screener allows us to run high throughput screening assays against primary cell types monitoring drug action in a way that simply wasn't possible.
-
SLAS Discovery: High Throughput Flow Cytometry in Drug Discovery – Download Now
-
LIMITED TIME OFFER: FREE consumables with arium® mini compact Ultrapure Water System purchase. Learn More
-
Learn how scientists at ModiQuest Research Streamlined their Antibody Discovery Workflow
-
passionforscience.com – Learn about available expertise, technical innovation, and career development programs at Sartorius
-
Get $10K of FREE Sartorius Cell Culture Products when you purchase an iQue Screener PLUS >>Learn How
-
Expedite your antibody discovery with the new Mouse IgG Type and Titer Assay
-
ForeCyt 6.2 Software Update available – UPGRADE NOW!
-
Information-Rich Solutions to Transform Cell Therapy Research and Discovery. Learn More.
High Throughput Suspension Cell Analysis
The Intellicyt iQue Screener PLUS
The fastest path to actionable results
Watch the Video
Cell Analysis industry leaders Intellicyt and Essen BioScience are now Sartorius
Optimize. Analyze. Visualize. Realize…
Faster than ever before!
Discover a whole new analysis workflow.
Special Issue: Free Digital Edition
High Throughput Flow Cytometry in Drug Discovery
Download this issue to get access to a collection of research papers, application notes, and technical notes from leading pharmaceutical and academic organizations that provide new insights and perspectives for the design of high throughput flow cytometry platforms and highlight its broad range of applications in drug discovery.
New Product Announcement
Intellicyt® Mouse IgG Type and Titer Assay Kit: A Novel Solution to Expedite Antibody Discovery
Analyze Isotype, Titer and Cell Health in One Assay!
Working at Intellicyt
We are always on the lookout for talented, passionate individuals to join our team.
Latest Announcements
25
Sep
Events
Webinar: Multiplexing Specificity and Species Cross Reactivity in Biologics Discovery
During biologics discovery the ability to evaluate antigen-antibody interactions via multiplexed binding assays at high throughput provides more comprehensive information in the primary screening phase. Identifying hits by simultaneous evaluation...
09
Oct